LPAR1 anticorps (C-Term)

N° du produit ABIN306575

Détail du produit anti-LPAR1 anticorps

Antigène: LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))

Épitope: C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LPAR1 est non-conjugé

Application: Western Blotting (WB)

Isotype: IgG

Information d'application

Indications d'application: For Western blotting, starting dilution of 5-10 ug/ml is recommended. Western blot should be visualized using a high sensitivity secondary/substrate system (i.e. Pierce

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/ml

Stock: -20 °C

Détails sur LPAR1

Antigène: LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))

Autre désignation: Lysophosphatidic Acid Receptor 1 CT (EDG-2) (LPAR1 Produits)

Synonymes: anticorps EDG2, anticorps GPR26, anticorps Gpcr26, anticorps LPA1, anticorps Mrec1.3, anticorps VZG1, anticorps edg-2, anticorps rec.1.3, anticorps vzg-1, anticorps Edg2, anticorps EDG-2, anticorps 5031439C20, anticorps AI326300, anticorps Kdt2, anticorps lpA1, anticorps edg2, anticorps si:dz22b13.1, anticorps si:dz46m7.1, anticorps zgc:92157, anticorps LPA receptor 1-A, anticorps LPA-1-A, anticorps gpr26, anticorps lpa1, anticorps lpa1r, anticorps lpa1r1, anticorps lpar1, anticorps lpar1-a, anticorps lpar1-b, anticorps vzg1, anticorps xLPA1-1, anticorps LPA receptor 1-B, anticorps LPA-1-B, anticorps edg2-A, anticorps xLPA1-2, anticorps xlpa1R, anticorps lysophosphatidic acid receptor 1, anticorps lysophosphatidic acid receptor 1 S homeolog, anticorps lysophosphatidic acid receptor 1 L homeolog, anticorps LPAR1, anticorps Lpar1, anticorps lpar1, anticorps lpar1.S, anticorps lpar1.L

Sujet: Endothelial cell differentiation gene-2 (EDG-2) receptor is a high affinity receptor for lysophosphatidic acid (LPA). EDG-2, also known as lysophospholipid receptor A1, Vzg-1, mrec1.3 or GPCR26, like all other EDG receptors, couple multiple (3 or more) types of G proteins and transduce decreases in c[AMP]i through Gi and increases in [Ca2+]i by augmenting phospholipase C through Gq/11 and beta/gamma dimers and by induction of PI3 kinase, p125 FAK, phospholipase D by activating rho through G12/13. Human EDG-2 is present in high levels on oligodendrocytes and certain human malignant T cell lines. EDG-2 receptors (with EDG-4) may play a role in protecting cardiomyocytes from apoptosis induced by hypoxia and andrenergic stimulation. Synonyms: Endothelial Cell Differentiation Gene Receptor 2, Lysophosphatidic Acid Receptor 1.

Pathways: Myometrial Relaxation and Contraction, Smooth Muscle Cell Migration